home.aspx
 
. https://www.genengnews.com/news/pfizer-biontech-plan-clinical-trial-for-covid-19-mrna-vaccine-candidate/
article
SHARESHARESHARE
PFIZER, BIONTECH PLAN CLINICAL TRIAL FOR COVID-19 MRNA VACCINE CANDIDATE
Pfizer and BioNTech plan to begin human clinical trials on their lead COVID-19 therapeutic candidate, an mRNA vaccine, by the end of this month, the companies said today, through a collaboration that could generate up to $748 million for the German biotech. The companies announced plans last month to partner on BNT162, the first treatment to emerge from BioNTech’s accelerated COVID-19-focused development program, “Project Lightspeed.” BioNTech and Pfizer established collaboration intended to draw upon BioNTech’s proprietary mRNA vaccine platforms, and Pfizer’s expertise in vaccine research and development, regulatory capabilities, and global manufacturing and distribution network. READ MORE